Perrigo Company PLC
http://www.perrigo.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Perrigo Company PLC
Perrigo Adds High-Strength Paracetamol To UK Solpadeine Line
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Perrigo’s Consumer Health Brand Talk Gets An Executive Voice With First Brand Chief Appointed
David Ball moves from Bayer’s North America business to be Perrigo’s first chief brand and digital officer. He joins CEO who also moved to Perrigo from Bayer with decades of branded product experience.
Perrigo Q2 Results Down Nearly 11% On Formula Slump Despite Women’s Health Sales Jump On Opill
OTC private label/store brand product giant’s Q2 net sales down 10.7% to $1.1bn, but women’s health product sales jump 31.4% largely on Opill launched late in Q1. Biggest hit to results from infant formula business, down a reported 82% due to ongoing manufacturing quality-control remediation.
US Consumer Health Q2 Earnings Preview: If Not For Headwinds, Tailwinds Would Be Trending
Analysts tracking consumer health product firms in the US anticipatevApril-June results lower than a year ago across most businesses. While some results will be lower on comparisons with strong growth in 2023, others will reflect a slow allergy season, retailers’ inventories remaining high as consumer spending slows or firms continuing to recover from supply chain problems.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Agis Industries
- Chemagis
- Clay-Park Labs
- Cobrek Pharmaceuticals
- Elan Corporation
- JB Laboratories
- Onclave Therapeutics Limited
- Omega Pharma Invest N.V.
- Paddock Laboratories
- Omega Pharma Invest N.V.
- Ranir Global Holdings LLC
- Rosemont Pharmaceuticals Ltd.
- Unico Holdings Inc.
- Velcera, Inc.
- Geiss, Destin & Dunn, Inc.
- High Ridge Brands
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice